Insulin receptor H1085H C>T and insulin receptor substrate 1 G972R polymorphisms and prostate cancer risk: A pilot study

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 3, 2011, Pages 127-131

  Saracevic, Andrea ^a   Nikolac, Nora ^a   Reljic, Ante ^a   Simundic, Ana Maria ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; GENETIC VARIABILITY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PILOT STUDY; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; AGED, 80 AND OVER; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MALE; MIDDLE AGED; PILOT PROJECTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSTATIC NEOPLASMS; RECEPTOR, INSULIN; SEVERITY OF ILLNESS INDEX;

EID: 79952126807     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0112     Document Type: Article

References (32)

1. Almind K, Inoue G, Pedersen O, et al. (1996) A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest 97:2569-2575.
2. Baserga R (2009) The insulin receptor substrate-1: a biomarker for cancer? Exp Cell Res 315:727-732.
3. Bostwick DG, Foster CS (1999) Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International C (Pubitemid 30030105)
4. Chen B, Liu S, Wang XL, et al. (2009) TRAIL-R1 polymorphisms and cancer susceptibility: an evidence-based meta-analysis. Eur J Cancer 45:2598-2605.
5. Cox ME, Gleave ME, Zakikhani M, et al. (2009) Insulin receptor expression by human prostate cancers. Prostate 69:33-40.
6. Dong LM, Brennan P, Karami S, et al. (2009) An analysis of growth, differentiation and apoptosis genes with risk of renal cancer. PLoS ONE 4:e4895.
7. Eng-Wong J, Perkins SN, Bondy M, et al. (2009) Premenopausal breast cancer: estrogen receptor status and insulin-like growth factor-I (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), and leptin. Breast J 15:426-428.
8. Fall K, Stark JR, Mucci LA, et al. (2008) No association between a polymorphic variation of the IRS1 gene and prostate cancer risk. Prostate 8:1416-1420.
9. Federici M, Hribal ML, Ranalli M, et al. (2001) The common Arg972 polymorphism in insulin receptor substrate-1 causes apoptosis of human pancreatic islets. FASEB J 15:22-24.
10. Giovannucci E (2003) Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 35:694-704. (Pubitemid 38058173)
11. Gleason DF (1966) Classification of prostatic carcinomas. Cancer Chemother Rep 50:125-128.
12. Godsland IF (2009) Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond) 118:315-332.
13. Holt SK, Kwon EM, Peters U, et al. (2009) Vitamin D pathway gene variants and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 18:1929-1933.
14. Hribal ML, Federici M, Porzio O, et al. (2000) The Gly->Arg972
15. amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. J Clin Endocrinol Metab 85:2004-2013.
16. Jakubowska A, Gronwald J, Menkiszak J, et al. (2007) Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk. J Med Genet 44:408-411. (Pubitemid 46953725)
17. Jemal A, Siegel R, Ward E, et al. (2009) Cancer Statistics, 2009. CA Cancer J Clin 59:225-249.
18. Karatzas A, Giannatou E, Tzortzis V, et al. (2010) Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men. Cancer Epidemiol 34:345-349.
19. Li L, Cicek MS, Casey G, et al. (2005) No association between genetic polymorphisms in insulin and insulin receptor substrate-1 and prostate cancer. Cancer Epidemiol Biomarkers Prev 14:2462-2463. (Pubitemid 41437855)
20. Ma Z, Tsuchiya N, Yuasa T, et al. (2008) Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population. Int J Cancer 123:2574-2579.
21. Moore SC, Leitzmann MF, Weinstein SF, et al. (2007) Insulin resistance-related polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 16:1315-1317. (Pubitemid 46984980)
22. Neuhausen SL, Slattery ML, Garner CP, et al. (2005) Prostate cancer risk and IRS1, IRS2, IGF1 and INS polymorphisms: strong association of IRS1 G972R variant and cancer risk. Prostate 64:168-174. (Pubitemid 40791766)
23. Pollak MN, Schernhammer ES, Hankinson SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505-518. (Pubitemid 38868620)
24. Reiss K, Wang JY, Romano G, et al. (2001) Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells. Oncogene 20:490-500. (Pubitemid 32158229)
25. Reljic A, Simundic AM, Topic E, et al. (2007) The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study. Clin Biochem 40:981-985. (Pubitemid 47301797)
26. Renehan AG, Zwahlen M, Minder C, et al. (2004) Insulin-like growth factor (IGF)-1, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346-1353. (Pubitemid 38529873)
27. Rowlands MA, Gunnell D, Harris R, et al. (2009) Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer 124:2416-2429.
28. Sentinelli F, Filippi E, Cavallo MG, et al. (2006) The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation. J Endocrinol 188:271-285. (Pubitemid 43273815)
29. Siegel S, Futterweit W, Davies TF, et al. (2002) A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertil Steril 78:1240-1243. (Pubitemid 35469148)
30. Takahari D, Yamada Y, Okita NT, et al. (2009) Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer. Oncology 76:42-48.
31. van Dam RM, Hoebe B, Seidel JC, et al. (2004) The insulin receptor substrate-1 Gly972Arg polymorphism is not associated with Type 2 diabetes mellitus in two population-based studies. Diabet Med 21:752-758. (Pubitemid 38916221)
32. Wang Y, McCullough ML, Stevens VL, et al. (2007) Nested casecontrol study of energy regulation candidate gene single nucleotide polymorphisms and breast cancer. Anticancer Res 27:589-593. (Pubitemid 46374981)